Search - tctmd.com

Displaying 61 - 80 of 553

Sort: Relevancy | Date

Presentation TCT 2017

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation - Are the Results Enough to Change Practice?

Presenter: Deepak L. Bhatt, C. Michael Gibson

November 01, 2017

Presentation TCT 2017

Case #4 (With Discussion): A Patient With STEMI and Multivessel Disease

Presenter: Henning Kelbæk, Renu Virmani

November 01, 2017

Presentation TCT 2017

When Bleeding Occurs on Warfarin or NOAC: Reversal Strategies

Presenter: Robert A. Harrington, Kurt Huber, Michael D. Ezekowitz

November 01, 2017

Presentation TCT 2017

TCT 112: Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention - A Pilot Clinical Study

Presenter: Patrick W. Serruys, Liansheng Wang, MD

November 01, 2017

Presentation TCT 2017

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic Atrial Fibrillation Patient Who Requires PCI

Presenter: Robert A. Harrington, Kurt Huber, Christopher B. Granger

November 01, 2017

Presentation TCT 2017

State-of-the-Art Review: Intravascular Imaging and Physiology in ACS - Culprit Lesion and Vulnerable Plaque Assessment

Presenter: Henning Kelbæk, Renu Virmani, Francesco Prati

November 01, 2017

Presentation TCT 2017

When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy?

Presenter: Robert A. Harrington, Kurt Huber, Roxana Mehran

November 01, 2017

Presentation TCT 2017

TCT 111: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Female Patients

Presenter: Patrick W. Serruys, Konstantinos Voudris

November 01, 2017

Presentation TCT 2017

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

Presenter: Robert A. Harrington, Kurt Huber, Michelle O'Donoghue

November 01, 2017

Presentation TCT 2017

Impact of PSP in ACS: BVS STEMI First and BVS EXPAND

Presenter: Nick E. J. West, Joanna J. Wykrzykowska, Robert-Jan van Geuns

November 01, 2017

Presentation TCT 2017

TCT 110: Periprocedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs CABG for Left Main Disease - Analysis From the EXCEL Trial

Presenter: Patrick W. Serruys, Ori Ben-Yehuda

November 01, 2017

Presentation TCT 2017

Should the Type of Stent Influence DAPT Decisions in Patients Receiving OAC? Insights From WOEST, LEADERS Free, and More

Presenter: Robert A. Harrington, Kurt Huber, Didier Carrié

November 01, 2017

Presentation TCT 2017

Guidelines and Expert Consensus on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI: How Strong Is the Evidence?

Presenter: Robert A. Harrington, Kurt Huber, Jean-François Tanguay

November 01, 2017

Presentation TCT 2017

TCT 109: Ten-year Clinical Outcome in Patients With Coronary Chronic Total Occlusions Not Revascularized by Percutaneous Coronary Intervention

Presenter: Patrick W. Serruys, Cosmo Godino, MD

November 01, 2017

News Conference News TCT 2017

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

Todd Neale

November 01, 2017

Presentation TCT 2017

What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants

Presenter: Robert A. Harrington, Kurt Huber, Freek W.A. Verheugt

November 01, 2017

Presentation TCT 2017

DEFINE FLAIR/SWEDEHEART: Critique and Unanswered Questions

Presenter: David J. Cohen, Ajay J. Kirtane, Habib Samady

November 01, 2017

Presentation TCT 2017

DEFINE FLAIR/SWEDEHEART: Topline Findings and Practice Implications

Presenter: David J. Cohen, Ajay J. Kirtane, Thomas Engstroem

November 01, 2017

Presentation TCT 2017

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy

Presenter: Robert A. Harrington, Kurt Huber, Renato D. Lopes

November 01, 2017

Presentation TCT 2017

Management of Acute Coronary Syndromes: Bangladesh Perspective and Insights Into Regional Variations

Presenter: Vinay K. Bahl, Alice K. Jacobs, Abdul Kader Akanda

November 01, 2017

Advertisement

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation - Are the Results Enough to Change Practice?

Case #4 (With Discussion): A Patient With STEMI and Multivessel Disease

When Bleeding Occurs on Warfarin or NOAC: Reversal Strategies

TCT 112: Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention - A Pilot Clinical Study

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic Atrial Fibrillation Patient Who Requires PCI

State-of-the-Art Review: Intravascular Imaging and Physiology in ACS - Culprit Lesion and Vulnerable Plaque Assessment

When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy?

TCT 111: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Female Patients

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

Impact of PSP in ACS: BVS STEMI First and BVS EXPAND

TCT 110: Periprocedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs CABG for Left Main Disease - Analysis From the EXCEL Trial

Should the Type of Stent Influence DAPT Decisions in Patients Receiving OAC? Insights From WOEST, LEADERS Free, and More

Guidelines and Expert Consensus on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI: How Strong Is the Evidence?

TCT 109: Ten-year Clinical Outcome in Patients With Coronary Chronic Total Occlusions Not Revascularized by Percutaneous Coronary Intervention

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants

DEFINE FLAIR/SWEDEHEART: Critique and Unanswered Questions

DEFINE FLAIR/SWEDEHEART: Topline Findings and Practice Implications

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy

Management of Acute Coronary Syndromes: Bangladesh Perspective and Insights Into Regional Variations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content